Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

09/06/2016

Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Morgan Stanley 2016 Global Health Care Conference on Tuesday, September 13, 2016, in New York. Giovanni Caforio, M.D., chief executive officer will make formal remarks about the company and answer questions at 11:10 a.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitter, YouTube and Facebook.

Bristol-Myers Squibb Media:Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors:Tim Power, 609-252-7509 timothy.power@bms.com Bill Szablewski, 609-252-5894 william.szablewski@bms.com

Multimedia Files:

Categories: Press Releases